Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.603
+0.015 (0.94%)
Jul 24, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 633.65 million as of July 24, 2026. Its market cap has decreased by -39.51% in one year.
Market Cap
633.65M
Enterprise Value
567.29M
Revenue
83.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
ChartMarket Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 633.65M, a decrease of -62.05%. That is a compound annual growth rate of -9.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 633.65M | -51.64% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.09B |
| SynAct Pharma AB | 1.02B |
| AlzeCure Pharma AB | 910.12M |
| Infant Bacterial Therapeutics AB | 875.64M |
| Xspray Pharma AB | 740.65M |
| FluoGuide | 536.26M |
| Cantargia AB | 467.39M |
| Corline Biomedical AB | 454.72M |